New Hypertension Treatments
High blood pressure is a very common disease in the US; over 70% of the American people aged 60 to 80 suffer from this condition. High blood pressure, also known as hypertension, appears when the arteries are constricted for a long period of time. There are many drugs that treat high blood pressure, but they often time have secondary effects, leading to fatigue, for example.
New research has revealed the fact that the angiotensin receptor named AT1R plays a crucial part when it comes to blood pressure control. This isn’t exactly breaking news, but the scientists were now able to determine the receptor structure at an atomic scale, highlighting the way in which AT1R and the blood pressure medication interacts.
The researchers hope to be able to develop a new generation of hypertension drugs that will have fewer unwanted effects.
Hypertension Risk Factors Increasing In Asia
The Journal of the American College of Cardiology has published an article that states a troubling fact: hypertension affects only the US and Europe, but also Asia, and particularly Japan.
While the high blood pressure figures in the US aren’t rising, Japan is facing a decade that has seen more and more people suffering from hypertension. The American doctors have managed to lower these troubling numbers by educating the population and by providing effective medication. Let’s hope that the Asian doctors will do the same.
Hypertension Medication May Reduce the Risk of Alzheimer’s Disease
New research suggest that people who suffer from hypertension have a lower risk of suffering from Alzheimer’s disease. The study hasn’t managed to differentiate if low risk is due to hypertension, or if it is a side effect of the high blood pressure medication.
The study has analyzed data for over 54,000 people, and about 31% of them were suffering from Alzheimer’s. Some of the researchers believe that hypertension is protective in itself, while others believe that the antihypertensive medication is protecting people from Alzheimer’s disease.